NCT07045233View on ClinicalTrials.gov

A Clinical Study on the Use of the Sentinel Cerebral Protection Device During TAVR for the Prevention of Procedure-Related Stroke

Enrolling by invitationOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

July 31, 2028

Conditions
StrokeTranscatheter Aortic Valve Replacement (TAVR)Aortic Stenosis Treated With TAVI
Interventions
DEVICE

Sentinel® Cerebral Protection System

Deploy a Sentinel cerebral protection device during TAVR for patient with aortic stenosis.

DIAGNOSTIC_TEST

MRI

Patients receive head MRI before and after the surgery in order to determine the stroke incidence.

Trial Locations (1)

Unknown

Fuwai Hospital, Beijing

All Listed Sponsors
lead

China National Center for Cardiovascular Diseases

OTHER_GOV